Cheung Ky
Department of Clinical Oncology, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
Biomed Imaging Interv J. 2006 Jan;2(1):e19. doi: 10.2349/biij.2.1.e19. Epub 2006 Jan 1.
Intensity modulated radiotherapy (IMRT) is widely used in clinical applications in developed countries, for the treatment of malignant and non-malignant diseases. This technique uses multiple radiation beams of non-uniform intensities. The beams are modulated to the required intensity maps for delivering highly conformal doses of radiation to the treatment targets, while sparing the adjacent normal tissue structures. This treatment technique has superior dosimetric advantages over 2-dimensional (2D) and conventional 3-dimensional conformal radiotherapy (3DCRT) treatments. It can potentially benefit the patient in three ways. First, by improving conformity with target dose it can reduce the probability of in-field recurrence. Second, by reducing irradiation of normal tissue it can minimise the degree of morbidity associated with treatment. Third, by facilitating escalation of dose it can improve local control. Early clinical results are promising, particularly in the treatment of nasopharyngeal carcinoma (NPC). However, as the IMRT is a sophisticated treatment involving high conformity and high precision, it has specific requirements. Therefore, tight tolerance levels for random and systematic errors, compared with conventional 2D and 3D treatments, must be applied in all treatment and pre-treatment procedures. For this reason, a large-scale routine clinical implementation of the treatment modality demands major resources and, in some cases, is impractical. This paper will provide an overview of the potential advantages of the IMRT, methods of treatment delivery, and equipment currently available for facilitating the treatment modality. It will also discuss the limitations of the equipment and the ongoing development work to improve the efficiency of the equipment and the treatment techniques and procedures.
调强放射治疗(IMRT)在发达国家的临床应用中被广泛用于治疗恶性和非恶性疾病。该技术使用强度不均匀的多个辐射束。这些束被调制为所需的强度分布图,以便向治疗靶区提供高度适形的辐射剂量,同时 sparing 相邻的正常组织结构。这种治疗技术比二维(2D)和传统三维适形放射治疗(3DCRT)具有更好的剂量学优势。它可能在三个方面使患者受益。首先,通过提高与靶剂量的适形性,它可以降低靶区内复发的概率。其次,通过减少对正常组织的照射,它可以将与治疗相关的发病程度降至最低。第三,通过促进剂量递增,它可以提高局部控制率。早期临床结果很有前景,特别是在鼻咽癌(NPC)的治疗中。然而,由于IMRT是一种涉及高适形性和高精度的复杂治疗方法,它有特定的要求。因此,与传统的2D和3D治疗相比,在所有治疗和预处理程序中必须应用对随机和系统误差的严格容忍水平。出于这个原因,该治疗方式的大规模常规临床实施需要大量资源,并且在某些情况下是不切实际的。本文将概述IMRT的潜在优势、治疗实施方法以及目前可用于促进该治疗方式的设备。它还将讨论设备的局限性以及为提高设备效率和治疗技术及程序而正在进行的开发工作。 (注:文中 sparing 一词未准确译出合适中文,暂保留英文)